Study Findings Support Furtherance of GED-0507 for IPF

Study Findings Support Furtherance of GED-0507 for IPF

GED-0507, Nogra Pharma’s experimental therapy, significantly reduced the levels of pro-inflammatory and pro-scarring molecules, while suppressing the maturation of myofibroblasts — the main drivers of lung scarring (fibrosis) — to a similar or greater extent as two approved anti-fibrotic therapies. These findings, based on data from mice with induced…

30 Days of PF: Make Every Breath Count

Photo courtesy of Aishia Burnett Day 30 of 30 This is Aishia Burnett’s story: January 2015: Picture it: I was working full time, going to school part time, a mom to two high schoolers, happily married to my best friend. I got pneumonia and my doctor sent me for…

Close Friends Can Provide Valuable Insight When We’re Anxious

Friendships can change when chronic illnesses like idiopathic pulmonary fibrosis (IPF) enter the picture. Some might struggle to understand a friend’s illness, needs, and limitations. And the friend with the illness might change too, depending on how they cope. However, I believe true friendships can withstand these challenges, and even…

Focusing on Wins for Pulmonary Fibrosis Awareness Month

You may have noticed that September is Pulmonary Fibrosis Awareness Month. Here at Pulmonary Fibrosis News, we’ve been running a social media campaign that showcases patients and their loved ones in our community. Additionally, the Pulmonary Fibrosis Foundation runs a yearly campaign encouraging advocates to “let the world know”…

Tony Award Recognizes Actress for Work as PF Advocate

Julie Halston, a Broadway theater veteran and comedian, has received the 2020 Isabelle Stevenson Tony Award for her longtime volunteer efforts for the Pulmonary Fibrosis Foundation (PFF). Halston, who is part of the PFF board, has raised more than $2 million for the organization. She also helped to bring…

30 Days of PF: An Outsider’s Perspective

Photo courtesy of Kevin Schaefer Day 28 of 30 This is Kevin Schaefer’s story: Four years ago, I accepted a position at Bionews Services, the parent company of Pulmonary Fibrosis News. Having lived with a neuromuscular condition called spinal muscular atrophy my entire life, I already had a…

Syndax, Incyte Join Forces to Develop Axatilimab for IPF

Syndax Pharmaceuticals and Incyte are forming a global partnership to develop and commercialize axatilimab, an investigational therapy for idiopathic pulmonary fibrosis (IPF) and other diseases characterized by excessive scarring. The companies are planning to launch a proof-of-concept Phase 2 clinical trial to test axatilimab in IPF patients…

30 Days of PF: We Are Stronger Together

Photo courtesy of Andrew Mooney Day 27 of 30 This is Andrew Mooney’s story: I was diagnosed with IPF nine years ago and am living with my condition as best I can. My wife, Lyn, has been at my side from the start and has been a constant…

Your PF Community

Woman laying down reading

Visit the Pulmonary Fibrosis News forums to connect with others in the PF community.

View Forums